Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial
体重调整中等剂量与固定剂量低分子肝素预防性抗凝治疗对非重症和重症 COVID-19 患者静脉血栓栓塞的影响：COVI-DOSE 试验，一项多中心、随机、开放标签的 4 期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.102031
Zuily, Stéphane; Lefèvre, Benjamin; Sanchez, Olivier; Empis de Vendin, Ombeline; de Ciancio, Guillaume; Arlet, Jean-Benoît; Khider, Lina; Terriat, Béatrice; Greigert, Hélène; Robert, Céline S; Louis, Guillaume; Trinh-Duc, Albert; Rispal, Patrick; Accassat, Sandrine; Thiery, Guillaume; Montani, David; Azarian, Réza; Meneveau, Nicolas; Soudet, Simon; Le Mao, Raphaël; Maurier, François; Le Moing, Vincent; Quéré, Isabelle; Yelnik, Cécile M; Lefebvre, Nicolas; Martinot, Martin; Delrue, Maxime; Benhamou, Ygal; Parent, Florence; Roy, Pierre-Marie; Presles, Emilie; Goehringer, François; Mismetti, Patrick; Bertoletti, Laurent; Rossignol, Patrick; Couturaud, Francis; Wahl, Denis; Thilly, Nathalie; Laporte, Silvy
